Pitt spinout BlueSphere Bio has attracted an initial $45.6m in series B funding towards a $105m target size.

SoftBank Ventures Asia has led the sports shoe resale platform’s series A and B rounds, investing alongside participants including Colopl Next and The Guild.

The Intel-backed healthcare analytics technology provider has closed a new round with investments from AllegisNL Capital and Blue Venture Fund.

Shenzhen Capital Group has provided tens of millions of yuan for Xiaomi-backed monitor projecting technology developer Happycast.

Visa participated in an $18.8m round for the subscription management technology provider that pushed its total funding above $28m.

Verizon and Evertz Technologies co-led a round that took the basketball statistics and data technology provider's total funding to $32m.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Lundbeck and Novo were among the participants in the immuno-oncology drug developer's series B round having backed its series A four years ago.

The eye disease device developer has raised series B funding to advance research originating from University of Colorado's s Sue Anschutz-Rodgers Eye Center.

The driverless vehicle technology developer has added $110m to the $200m supplied by busmaker Yutong Group last month.